Legacy Capital Group California, Inc. Amicus Therapeutics, Inc. Transaction History
Legacy Capital Group California, Inc.
- $328 Billion
- Q4 2024
A detailed history of Legacy Capital Group California, Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 23,229 shares of FOLD stock, worth $205,808. This represents 0.07% of its overall portfolio holdings.
Number of Shares
23,229
Previous 19,329
20.18%
Holding current value
$205,808
Previous $206 Million
6.0%
% of portfolio
0.07%
Previous 0.07%
Shares
2 transactions
Others Institutions Holding FOLD
# of Institutions
312Shares Held
311MCall Options Held
467KPut Options Held
515K-
Vanguard Group Inc Valley Forge, PA29.3MShares$259 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA28.5MShares$252 Million0.05% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$216 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY24.2MShares$215 Million7.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$205 Million3.18% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.49B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...